|
|
|
|
| Advertisement |
The recent paper on drug pricing from the American College of Physicians ignores economic reality. Read an expert evaluation that pharma needs to understand from global pricing expert Ed Schoonveld.
 Learn more |
| EUROPE |
|
|
NICE Lite?
|
Is a more "light-touch" appraisal process the key to getting the UK's NICE to do more with less? This is one of the options the organization has put forward for consultation this week. Leela Barham reports.
... /Read more/ |
|
|
| Advertisement |
Watch this brief video to hear how trusted case managers can drive patient adherence and better outcomes using in-home education and tele-health support.
 Learn more |
|
| Europe |
|
|
Patching Up Europe’s Data Deficiencies
|
The Innovative Medicines Initiative, a drug research program run by the European Commission and the EFPIA, is inviting bids to run a pilot program regarding preclinical research and development
... /Read more/ |
|
|
| Advertisement |
Strategic considerations for clinical development programs in emerging biopharma companies
May 25 at 10 – 11AM EST
 Learn more |
|
| Advertisement |
Understanding the Chronic Disease Patient Journey in Emerging Markets
On Demand
 Read more |
| Special Feature |
|
|
Pharm Exec’s Brand of the Year 2016
|
Pharm Exec's 10th annual Brand of the Year is Bristol-Myers Squibb's Opdivo, which has raced into the lead position in the treatment-shifting immuno-oncology space behind launches in three key cancers—melanoma, lung, and renal
... /Read more/ |
|
|
|
| Calendar |
|
| Advertisement |
Precision asset valuation Leveraging insights from clinical and market access big data
On Demand
 Read more |
|
|
|
 |
| Advertisement |
Medical science liaisons Optimizing their impact during product launch
On Demand
 Read more |
|
| Industry update |
| //Novartis has split its pharmaceuticals division into two separate business units, one focused on drug development and the other dedicated to treatments for cancer. The company has since announced the departure of David Epstein, who had been the head of the pharmaceuticals division.//Kite Pharma, Inc. (Santa Monica, CA) appointed Paul L. Jenkinson as Chief Financial Officer.//Codiak BioSciences Inc. (Woburn, MA) announced the appointment of Jan Lötvall, M.D., Ph.D., as Chief Scientist.//Relmada Therapeutics (New York, NY) announced the promotion of Michael D. Becker to CFO.// |
|
|
| |
|
|
